Core B
Core B
批准号:
10339364
负责人:
Galit Alter
金额:
$99.39万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-02-01 至 2025-01-31
关键词:
AntibodiesAntibody ResponseBindingBiological AssayBiometryCell physiologyCellsClinicalComplementDataDevelopmentEnsureEpitopesFc ReceptorGoalsHIV vaccineHumanHuman ResourcesHumoral ImmunitiesImmuneImmune responseImmunityImmunologic MonitoringImmunologicsImmunologyInfectionInfection preventionInfrastructureInstitutesIsraelLeadershipLectinLinkMacaca mulattaMeasurementMediatingMedical centerMissionNeutralizing antibody assayPositioning AttributeProcessProteinsReagentRegimenResearch PersonnelRoleSIVSampling StudiesSerologySerumServicesStandardizationStatistical Data InterpretationSystemTechnical ExpertiseVaccinationVaccinesVirus DiseasesWorkneutralizing antibodynonhuman primatepathogenpreventprogramsrecruitresponsesimian human immunodeficiency virusvaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core B (Immunology Core) will provide standardized humoral immune monitoring assay services for
evaluating antibody responses elicited by Ad26-Env/Gag/Pol prime, Env gp140 protein boost (Ad26/Env)
vaccine regimens in the studies described in this IPCAVD program. Core B leadership will work closely
with investigators responsible for the studies described in Project 1 and Project 2 and will participate actively in
the scientific mission of the overall IPCAVD program. The primary goal of Core B is to provide the leadership
and the technical expertise to ensure that all vaccine-induced humoral responses will be profiled in a
standardized fashion and that the IPCAVD leadership is kept abreast of the latest developments in assessing
vaccine-induced neutralizing and non-neutralizing humoral immunity, particularly in relation to their ability to
prevent viral infection. To accomplish these goals, we propose the following three Specific Aims:
Specific Aim 1. To perform standardized neutralizing antibody (NAb) assays in both NHP and humans
Specific Aim 2. To perform standardized non-neutralizing antibody assays in both NHP and humans
Specific Aim 3. To integrate all antibody data into a Systems Serology profiling approach to define correlates
of protective immunity
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SARS-CoV-2 Variant Testing
-
批准号:10446500
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Systems Serology Core
-
批准号:10616544
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Systems Serology Core
-
批准号:10203487
-
项目类别:
-
资助金额:$39.61万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Systems Serology Core
-
批准号:10449292
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2021
-
负责人:Galit Alter
-
依托单位:
Defining humoral correlates of immunity against COVID-19
-
批准号:10265799
-
项目类别:
-
资助金额:$35.56万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
-
批准号:10221341
-
项目类别:
-
资助金额:$147.8万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
-
批准号:10159844
-
项目类别:
-
资助金额:$96.06万
-
财政年份:2020
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10158451
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10402341
-
项目类别:
-
资助金额:$69.29万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Antibody Optimization Core
-
批准号:10617741
-
项目类别:
-
资助金额:$62.43万
-
财政年份:2019
-
负责人:Galit Alter
-
依托单位:
Killing the Reservoir with Antibodies
-
批准号:9197410
-
项目类别:
-
资助金额:$48.61万
-
财政年份:2015
-
负责人:Galit Alter
-
依托单位:
Killing the Reservoir with Antibodies
-
批准号:8656251
-
项目类别:
-
资助金额:$23.56万
-
财政年份:2013
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8874097
-
项目类别:
-
资助金额:$87.64万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8408897
-
项目类别:
-
资助金额:$60.99万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8691723
-
项目类别:
-
资助金额:$84.27万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
Tuning Fc-effector functions of HIV-specific antibodies
-
批准号:8496714
-
项目类别:
-
资助金额:$67.25万
-
财政年份:2012
-
负责人:Galit Alter
-
依托单位:
The Innate Immune Signals on B Cells that Induce ADCC Antibodies
-
批准号:8332408
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2011
-
负责人:Galit Alter
-
依托单位:
The role of NK cells during acute HCV infection and antiviral therapy
-
批准号:7919782
-
项目类别:
-
资助金额:$17.12万
-
财政年份:2010
-
负责人:Galit Alter
-
依托单位:
Cytolytic antibodies:Bridging the gap between the innate and adaptive immune resp
-
批准号:8072923
-
项目类别:
-
资助金额:$43.39万
-
财政年份:2010
-
负责人:Galit Alter
-
依托单位:
Anergizing effect of NK cell receptor expression on HIV-specific CD8+ T cells
-
批准号:7900192
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2009
-
负责人:Galit Alter
-
依托单位:
海外基金